{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:20Z","timestamp":1790959160485,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004477","name":"Stellenbosch University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Emerging biomarkers of cancer cachexia and their roles in sarcopenia and prognosis are poorly understood. Baseline assessments of anthropometrics, sarcopenia, cachexia status and biomarkers of cachexia were measured in patients with advanced cancer and healthy controls. Thereafter, relationships of the biomarkers with cachexia and sarcopenia were explored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective case\u2013control design was used, including 40 patients with advanced cancer and 40 gender, age-matched controls. Bioelectrical impedance [skeletal muscle index (SMI)] and hand dynamometry [hand grip strength (HGS)] assessed sarcopenia and a validated tool classified cancer cachexia. Albumin, lymphocyte and platelet counts, haemoglobin, C-reactive protein (CRP), pro-inflammatory cytokines\/chemokines and citrullinated histone H3 (H3Cit) were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients had significantly lower SMI (6.67\u00a0kg\/m<jats:sup>2<\/jats:sup> versus 7.67\u00a0kg\/m<jats:sup>2<\/jats:sup>, <jats:italic>p<\/jats:italic>\u2009=\u2009\u2009&lt;\u20090.01) and HGS (24.42\u00a0kg versus 29.62\u00a0kg) compared to controls, with 43% being sarcopenic<jats:bold>.<\/jats:bold> Significant differences were found for albumin, lymphocyte and platelet counts, haemoglobin, CRP, and tumour necrosis factor \u03b1 (TNF\u03b1), (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Interleukin (IL)-6 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.04), IL-8 (<jats:italic>p<\/jats:italic>\u2009=\u20090.02), neutrophil\/lymphocyte ratio (NLR), <jats:italic>p<\/jats:italic>\u2009=\u20090.02, platelet\/lymphocyte (PLR) ratio, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 and systemic immune inflammatory index (SII), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 differed significantly. No difference was observed for CXC motif chemokine ligand 5 [CXCL5 or epithelial neutrophil-activating peptide 78 (ENA78)] or H3Cit. Albumin and haemoglobin correlated negatively with total protein, skeletal muscle mass and SMI (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). The presence of sarcopenia associated significantly with albumin, haemoglobin and CRP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Significant relationships and differences of haemoglobin, CRP and albumin supports future use of these biomarkers in cancer cachexia. CXCL5 and H3Cit as valuable biomarkers in cancer cachexia remains to be defined.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-023-05465-9","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:02:31Z","timestamp":1698735751000},"page":"17511-17527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Emerging markers of cancer cachexia and their relationship to sarcopenia"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5867-7669","authenticated-orcid":false,"given":"Melanie","family":"Lipshitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"5465_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2017.08.004","volume":"60","author":"C Alfaro","year":"2017","unstructured":"Alfaro C, Sanmamed M, Rodr\u00edguez-Ruiz M, Teijeira A, O\u00f1ate C, Gonz\u00e1lez A, Ponz M, Schalper K, L. P\u00e9rez-Gracia LJ, Melero I (2017) Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev 60:24\u201331. https:\/\/doi.org\/10.1016\/j.ctrv.2017.08.004","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"5465_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","volume":"7","author":"T Aoyagi","year":"2015","unstructured":"Aoyagi T, Terracina K, Raza A, Matsubara H, Takabe K (2015) Cancer cachexia, mechanism and treatment. World J Gastroint Oncol 7(4):17\u201329. https:\/\/doi.org\/10.4251\/wjgo.v7.i4.17","journal-title":"World J Gastroint Oncol"},{"issue":"4","key":"5465_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/CCO.0000000000000517","volume":"31","author":"J Argil\u00e9s","year":"2019","unstructured":"Argil\u00e9s J, Busquets S, Javier L (2019) Cancer cachexia, a clinical challenge. Curr Opin Oncol 31(4):286\u2013290. https:\/\/doi.org\/10.1097\/CCO.0000000000000517","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"5465_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SPC.0000000000000457","volume":"13","author":"D Brocco","year":"2019","unstructured":"Brocco D, Di Marino P, Grassandonia A (2019) From cachexia to obesity: the role of host metabolism in cancer immunotherapy. Curr Opin Support Palliat Care 13(4):305\u2013310. https:\/\/doi.org\/10.1097\/SPC.0000000000000457","journal-title":"Curr Opin Support Palliat Care"},{"issue":"11","key":"5465_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","volume":"12","author":"AR Bruggeman","year":"2016","unstructured":"Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ (2016) Cancer cachexia: beyond weight loss. J Oncol Pract 12(11):1163\u20131171. https:\/\/doi.org\/10.1200\/JOP.2016.016832","journal-title":"J Oncol Pract"},{"issue":"11","key":"5465_CR6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41430-020-0629-0","volume":"74","author":"A Bullock","year":"2020","unstructured":"Bullock A, Greenley S, McKenzie G, Paton L, Johnson M (2020) Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis. Eur J Clin Nutr 74(11):1519\u20131535. https:\/\/doi.org\/10.1038\/s41430-020-0629-0","journal-title":"Eur J Clin Nutr"},{"issue":"4","key":"5465_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/JES.0b013e3181f44f11","volume":"38","author":"J Carson","year":"2010","unstructured":"Carson J, Baltgalvis K (2010) Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev 38(4):168\u2013176. https:\/\/doi.org\/10.1097\/JES.0b013e3181f44f11","journal-title":"Exerc Sport Sci Rev"},{"issue":"3","key":"5465_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L Chen","year":"2020","unstructured":"Chen L, Woo J, Assantachai P et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Di Assoc 21(3):300\u2013307. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Di Assoc"},{"issue":"7","key":"5465_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1049909119886833","volume":"37","author":"L Cordeiro","year":"2020","unstructured":"Cordeiro L, Silva T, Costa de Oliveira L, Nogueira Neto J (2020) Systemic inflammation and nutritional status in patients on palliative cancer care: A systematic review of observational studies. Am J Hosp Palliat Med 37(7):565\u2013571. https:\/\/doi.org\/10.1177\/1049909119886833","journal-title":"Am J Hosp Palliat Med"},{"issue":"1","key":"5465_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.21037\/apm.2018.12.08","volume":"8","author":"J Crawford","year":"2019","unstructured":"Crawford J (2019) What are the citeria for response to cachexia treatment\u202f? Ann Palliat Med 8(1):43\u201349. https:\/\/doi.org\/10.21037\/apm.2018.12.08","journal-title":"Ann Palliat Med"},{"issue":"3","key":"5465_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.21873\/anticanres.11445","volume":"37","author":"A Daniele","year":"2017","unstructured":"Daniele A, Divella R, Abbate I, Casamassima A, Garrisi V, Savino E, Casamassima P, Ruggieri E, De Luca R (2017) Assessment of nutritional and inflammatory status to determine the prevalence of malnutrition in patients undergoing surgery for colorectal carcinoma. Anticancer Res 37(3):1281\u20131287. https:\/\/doi.org\/10.21873\/anticanres.11445","journal-title":"Anticancer Res"},{"issue":"1","key":"5465_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/apm.2018.08.07","volume":"8","author":"R Dev","year":"2018","unstructured":"Dev R (2018) Measuring cachexia\u2014diagnostic criteria. Ann Palliat Med. 8(1):24\u201332. https:\/\/doi.org\/10.21037\/apm.2018.08.07","journal-title":"Ann Palliat Med."},{"issue":"5","key":"5465_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ejso.2018.02.209","volume":"44","author":"A Dupr\u00e9","year":"2018","unstructured":"Dupr\u00e9 A, Malik H (2018) Inflammation and cancer: What a surgical oncologist should know. Eur J Surg Oncol 44(5):566\u2013570. https:\/\/doi.org\/10.1016\/j.ejso.2018.02.209","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"5465_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"K Fearon","year":"2012","unstructured":"Fearon K, Glass D, Guttridge D (2012) Review cancer cachexia: mediators, signaling, and metabolic pathways\u201d. Cel Metab 16(2):153\u2013166. https:\/\/doi.org\/10.1016\/j.cmet.2012.06.011","journal-title":"Cel Metab"},{"issue":"2","key":"5465_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10(2):90\u201399. https:\/\/doi.org\/10.1038\/nrclinonc.2012.209","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"5465_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4149\/318_151001N512","volume":"63","author":"O Fiala","year":"2016","unstructured":"Fiala O, Pesek M, Finek J, Racek J, Minarik M, Benesova L, Bortlicek Z, Sorejs O, Kucera R, Topolcan O (2016) Serum albumin is a strong predictor of survival in patients with advanced-tage non-small cell lung cancer treated with erlotinib. Neoplasma 63(3):471\u2013476. https:\/\/doi.org\/10.4149\/318_151001N512","journal-title":"Neoplasma"},{"issue":"12","key":"5465_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21124541","volume":"21","author":"E Gianazza","year":"2020","unstructured":"Gianazza E, Brioschi M, Baetta R, Mallia A, Banfi C, Tremoli E (2020) Platelets in healthy and disease states: from biomarkers discovery to drug targets identification by proteomics. Int J Mol Sci 21(12):1\u201344. https:\/\/doi.org\/10.3390\/ijms21124541","journal-title":"Int J Mol Sci"},{"key":"5465_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780195171693.001.0001","volume-title":"Principles of nutritional assessment","author":"R Gibson","year":"2005","unstructured":"Gibson R (2005) Principles of nutritional assessment. Oxford University Press, New York"},{"issue":"2","key":"5465_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/bjh.15906","volume":"186","author":"E Grilz","year":"2019","unstructured":"Grilz E, Mauracher L, Posch F, K\u00f6nigsbr\u00fcgge O, Z\u00f6chbauer-M\u00fcller S, Marosi C, Lang I, Pabinger I, Ay C (2019) Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer. Br J Haematol 186(2):311\u2013320. https:\/\/doi.org\/10.1111\/bjh.15906","journal-title":"Br J Haematol"},{"issue":"6","key":"5465_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","volume":"33","author":"M Haemmerle","year":"2018","unstructured":"Haemmerle M, Stone R, Menter D, Afshar-Kharghan V, Sood A (2018) The platelet lifeline to cancer: challenges and opportunities. Cancer Cell 33(6):965\u2013983. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.002","journal-title":"Cancer Cell"},{"issue":"27","key":"5465_CR21","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.18632\/oncotarget.27653","volume":"11","author":"N Hirahara","year":"2020","unstructured":"Hirahara N, Matsubara T, Fujii Y, Kaji S, Kawabata Y, Hyakudomi R (2020) Comparison of the prognostic value of immunoinflammation-based biomarkers in patients with gastric cancer. Oncotarget 11(27):2625\u20132635","journal-title":"Oncotarget"},{"issue":"12","key":"5465_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/jcm7120502","volume":"7","author":"Y Hou","year":"2018","unstructured":"Hou Y, Wang C, Chao J, Chen Y, Wang H, Tung H, Lin J, Shan Y (2018) Elevated serum interleukin-8 level correlates with cancer-related cachexia and sarcopenia: an indicator for pancreatic cancer outcomes. J Clin Med 7(12):502\u2013519. https:\/\/doi.org\/10.3390\/jcm7120502","journal-title":"J Clin Med"},{"issue":"12","key":"5465_CR23","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang X, Xu Y, Sun Y, Sun C, Guo W, Zhang X, Wang W, Qiu S, Zhou J, Fan J (2014) Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cncer Res 20(12):6212\u20136223. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0442","journal-title":"Clin Cncer Res"},{"key":"5465_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0562-7","author":"B Hu","year":"2018","unstructured":"Hu B, Fan H, Lv X, Chen S, Shao Z (2018) Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-018-0562-7","journal-title":"Cancer Cell Int"},{"issue":"2","key":"5465_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1519\/00139143-200932020-00008","volume":"32","author":"T Jones","year":"2009","unstructured":"Jones T, Stephenson K, King J, Knight K, Marshall T, Scott W (2009) Sarcopenia\u2014mechanisms and treatments. J Geriatr Phys Ther 32(2):39\u201345","journal-title":"J Geriatr Phys Ther"},{"issue":"8","key":"5465_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0161125","volume":"11","author":"E Kim","year":"2016","unstructured":"Kim E, Kim YS, Seo JY, Park I, Ahn HK, Kim JH, Kim N (2016) The relationship between sarcopenia and systemic inflammatory response for cancer cachexia in small cell lung cancer. PLoS ONE 11(8):1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0161125","journal-title":"PLoS ONE"},{"key":"5465_CR27","unstructured":"Kit, Clone Elisa (2018) Citrullinated Histone H3 (Clone 11D3) ELISA Kit. 3 (501620)"},{"issue":"7 SUPPL. 1","key":"5465_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjmed.2003.12.008","volume":"116","author":"K Knight","year":"2004","unstructured":"Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116(7 SUPPL. 1):11\u201326. https:\/\/doi.org\/10.1016\/j.amjmed.2003.12.008","journal-title":"Am J Med"},{"issue":"2","key":"5465_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.tranon.2018.01.007","volume":"11","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Kim JE, Kim ST, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY (2018) The correlation between serum chemokines and clinical outcome in patients with advanced biliary tract Cancer. Transl Oncol 11(2):353\u2013357. https:\/\/doi.org\/10.1016\/j.tranon.2018.01.007","journal-title":"Transl Oncol"},{"issue":"April","key":"5465_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcsm.12033","volume":"15","author":"L Lerner","year":"2015","unstructured":"Lerner L, Hayes TG, Tao N, Krieger B, Feng B, Wu Z, Nicoletti R, Chiu MI, Gyuris J, Garcia JN (2015) Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J Cachexia Sarcopenia Muscle 15(April):317\u2013324. https:\/\/doi.org\/10.1002\/jcsm.12033","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"5465_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/CMAR.S288522","volume":"13","author":"H Liang","year":"2021","unstructured":"Liang H, Peng H, Chen L (2021) Prognostic value of sarcopenia and systemic inflammation markers in patients undergoing definitive radiotherapy for esophageal cancer. Cancer Manag Res 13:181\u2013192. https:\/\/doi.org\/10.2147\/CMAR.S288522","journal-title":"Cancer Manag Res"},{"issue":"1","key":"5465_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cyto.2015.01.010","volume":"73","author":"JB Lim","year":"2015","unstructured":"Lim JB, Chung HW (2015) Serum ENA78\/CXCL5, SDF-1\/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Cytokine 73(1):16\u201322. https:\/\/doi.org\/10.1016\/j.cyto.2015.01.010","journal-title":"Cytokine"},{"key":"5465_CR33","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.2147\/CMAR.S175421","volume":"10","author":"J Lin","year":"2018","unstructured":"Lin J, Zhang W, Huang Y, Chen W, Wu R, Chen X, Lou N, Wang P (2018) Sarcopenia is associated with the neutrophil\/lymphocyte and platelet \/ lymphocyte ratios in operable gastric cancer patients: a prospective study. Cancer Manag Res 10:4935\u20134944. https:\/\/doi.org\/10.2147\/CMAR.S175421","journal-title":"Cancer Manag Res"},{"issue":"10","key":"5465_CR34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1097\/MEG.0000000000001535","volume":"31","author":"A Loktionov","year":"2019","unstructured":"Loktionov A, Soubieres A, Bandaletova T, Mathur J, Poullis A (2019) Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: Preliminary comparison of 24 protein biomarkers. Eur J Gastroenterol Hepatol 31(10):1220\u20131227. https:\/\/doi.org\/10.1097\/MEG.0000000000001535","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"14","key":"5465_CR35","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/onc.2012.201.Neutrophil","volume":"32","author":"MA Lopez-Lago","year":"2013","unstructured":"Lopez-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ, Changanti RSK (2013) Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression\u201d. Oncogene 32(14):1752\u20131760. https:\/\/doi.org\/10.1038\/onc.2012.201.Neutrophil","journal-title":"Oncogene"},{"issue":"18","key":"5465_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.clinbiochem.2017.07.011","volume":"50","author":"A Loumaye","year":"2017","unstructured":"Loumaye A, Thissen JP (2017) Biomarkers of cancer cachexia. Clin Biochem 50(18):1281\u20131288. https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.07.011","journal-title":"Clin Biochem"},{"key":"5465_CR37","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.3390\/ijms22062890","volume":"22","author":"A Maccio","year":"2021","unstructured":"Maccio A, Sanna E, Neri M, Oppi S, Madeddu C (2021) Cachexia as evidence of the mechanisms of resistance and tolerance during the evolution of cancer disease\u201d. Int J Mol Sci 22:2890. https:\/\/doi.org\/10.3390\/ijms22062890","journal-title":"Int J Mol Sci"},{"issue":"SEP","key":"5465_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2018.01294","volume":"9","author":"C Madeddu","year":"2018","unstructured":"Madeddu C, Gramignano G, Astara G, Demontis R, Sanna E, Atzeni V, Macci\u00f2 A (2018) Pathogenesis and treatment options of cancer related anemia: perspective for a targeted mechanism-based approach\u201d. Front Physiol 9(SEP):1\u201320. https:\/\/doi.org\/10.3389\/fphys.2018.01294","journal-title":"Front Physiol"},{"issue":"1","key":"5465_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","volume":"33","author":"L Martin","year":"2015","unstructured":"Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, Strasser F et al (2015) Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 33(1):90\u201399. https:\/\/doi.org\/10.1200\/JCO.2014.56.1894","journal-title":"J Clin Oncol"},{"issue":"16","key":"5465_CR40","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1158\/1078-0432.CCR-16-0495LK-","volume":"22","author":"Y Miyamoto","year":"2016","unstructured":"Miyamoto Y, Hanna DL, Zhang W, Baba H, Lenz HJ (2016) Molecular pathways: Cachexia signaling - a targeted approach to cancer treatment. Clin Cancer Res 22(16):3999\u20134004. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0495LK-","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5465_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-828","volume":"14","author":"P Mondello","year":"2014","unstructured":"Mondello P, Lacquaniti A, Mondello S, Bolignano D, Pitini V, Aloisi C, Buemi M (2014) Emerging markers of cachexia predict survival in cancer patients. BMC Cancer 14(1):1\u201310. https:\/\/doi.org\/10.1186\/1471-2407-14-828","journal-title":"BMC Cancer"},{"issue":"August","key":"5465_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SPC.0000000000000380","volume":"12","author":"R Montalvo","year":"2018","unstructured":"Montalvo R, Counts BR, Carson JA (2018) Understanding sex differences in the regulation of cancer-induced muscle wasting. Curr Opin Support Palliat Care 12(August):1. https:\/\/doi.org\/10.1097\/SPC.0000000000000380","journal-title":"Curr Opin Support Palliat Care"},{"key":"5465_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000503037","volume":"8521","author":"H Ohmori","year":"2019","unstructured":"Ohmori H (2019) Evaluation of parameters for cancer-induced sarcopenia in patients autopsied after death from colorectal cancer. Pathobiology Ff 8521:306\u2013314. https:\/\/doi.org\/10.1159\/000503037","journal-title":"Pathobiology Ff"},{"issue":"7","key":"5465_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1200\/OP.22.00674","volume":"19","author":"S Olaechea","year":"2023","unstructured":"Olaechea S, Sarver B, Liu A, Gilmore LA, Alvarez C, Iyengar P, Infante R (2023) Race, ethnicity, and socioeconomic factors as determinants of cachexia incidence and outcomes in a retrospective cohort of patients with gastrointestinal tract cancer. JCO Oncol Pract 19(7):493\u2013500. https:\/\/doi.org\/10.1200\/OP.22.00674","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"5465_CR45","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/01635581.2017.1321130","volume":"69","author":"GA Ozorio","year":"2017","unstructured":"Ozorio GA, Bar\u00e3o K, Forones NM (2017) Cachexia stage, patient-generated subjective global assessment, phase angle, and handgrip strength in patients with gastrointestinal cancer. Nutr Cancer 69(5):772\u2013779. https:\/\/doi.org\/10.1080\/01635581.2017.1321130","journal-title":"Nutr Cancer"},{"issue":"6","key":"5465_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21062040","volume":"21","author":"S Paczek","year":"2020","unstructured":"Paczek S, \u0141ukaszewicz-Zajac M, Gryko M, Mroczko P, Kulczy\u0144ska-Przybik A, Mroczko B (2020) CXCL-8 in preoperative colorectal cancer patients: Significance for diagnosis and cancer progression. Int J Mol Sci 21(6):1\u201313. https:\/\/doi.org\/10.3390\/ijms21062040","journal-title":"Int J Mol Sci"},{"issue":"March","key":"5465_CR47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcsm.12528","volume":"11","author":"S Peixoto","year":"2020","unstructured":"Peixoto S, Santos JMO, Silva MP, da Costa RM, Medeiros R (2020) Cancer cachexia and Its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle 11(March):619\u2013635. https:\/\/doi.org\/10.1002\/jcsm.12528","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"5465_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/oncsis.2016.3","volume":"5","author":"PE Porporato","year":"2016","unstructured":"Porporato PE (2016) Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 5(2):1\u201310. https:\/\/doi.org\/10.1038\/oncsis.2016.3","journal-title":"Oncogenesis"},{"issue":"4","key":"5465_CR49","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3945\/ajcn.113.060228","volume":"98","author":"CM Prado","year":"2013","unstructured":"Prado CM, Sawyer MB, Ghosh S, Lieffers JR, Esfandiari N, Antoun S, Baracos VE (2013) Central tenet of cancer cachexia therapy: Do patients with advanced cancer have exploitable anabolic potential? Am J Clin Nutr 98(4):1012\u20131019. https:\/\/doi.org\/10.3945\/ajcn.113.060228","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"5465_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1017\/S002966511500419X","volume":"75","author":"AM Ryan","year":"2016","unstructured":"Ryan AM, Power DG, Daly L, Cushen SJ, Bhuachalla EN, Prado CM (2016) Cancer-asociated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc 75(2):199\u2013211. https:\/\/doi.org\/10.1017\/S002966511500419X","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"5465_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","volume":"31","author":"C Scheede-Bergdahl","year":"2012","unstructured":"Scheede-Bergdahl C, Watt HL, Trutschnigg B, Kilgour RD, Haggarty A, Lucar E, Vigano A (2012) Is IL-6 the best pro-Inflammatory biomarker of clinical outcomes of cancer cachexia? Clin Nutr 31(1):85\u201388. https:\/\/doi.org\/10.1016\/j.clnu.2011.07.010","journal-title":"Clin Nutr"},{"issue":"11","key":"5465_CR52","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1007\/s00520-016-3287-y","volume":"24","author":"D Srdic","year":"2016","unstructured":"Srdic D, Plestina S, Sverko-Peternac A, Nikolac N, Simundic AM, Samarzija M (2016) Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer\u2014chemotherapy toxicity and prognostic value. Support Care Cancer 24(11):4495\u20134502. https:\/\/doi.org\/10.1007\/s00520-016-3287-y","journal-title":"Support Care Cancer"},{"issue":"6","key":"5465_CR53","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/jcsm.12477","volume":"10","author":"C Suetta","year":"2019","unstructured":"Suetta C, Haddock B, Alcazar J, Noerst T, Hansen OM, Ludvig H, Kamper RS, Schnohr P, Prescott E et al (2019) The Copenhagen sarcopenia study: Lean mass, strength, power, and physical function in a Danish cohort aged 20\u201393 years. J Cachexia Sarcopenia Muscle 10(6):1316\u20131329. https:\/\/doi.org\/10.1002\/jcsm.12477","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"5465_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0191231","volume":"13","author":"C Th\u00e5lin","year":"2018","unstructured":"Th\u00e5lin C, Lundstr\u00f6m S, Seignez C, Daleskog M, Lundstr\u00f6m A, Henriksson P, Helleday T, Phillipson M, Wall\u00e9n H, Demers M (2018) Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer\u201d. PLoS ONE 13(1):1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0191231","journal-title":"PLoS ONE"},{"issue":"10","key":"5465_CR55","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1111\/jth.15003","volume":"18","author":"C Th\u00e5lin","year":"2020","unstructured":"Th\u00e5lin C, Aguilera K, Hall NW, Marunde MR, Burg JM, Rosell A, Daleskog M et al (2020) Quantification of citrullinated histones: development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma. J Thromb Haemost 18(10):2732\u20132743. https:\/\/doi.org\/10.1111\/jth.15003","journal-title":"J Thromb Haemost"},{"key":"5465_CR56","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00520-019-04717-0","volume":"28","author":"B Wang","year":"2020","unstructured":"Wang B, Thapa S, Zhou T, Liu H, Li L (2020) Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia. Support Care in Cancer 28:581\u2013588. https:\/\/doi.org\/10.1007\/s00520-019-04717-0","journal-title":"Support Care in Cancer"},{"key":"5465_CR57","unstructured":"WHO (2019) Global Database on Body Mass Index. http:\/\/www.assessmentpsychology.com\/icbmi.htm. Accessed 11 Sep 2019"},{"key":"5465_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-35723-8","volume":"1224","author":"L Wu","year":"2020","unstructured":"Wu L, Saxena S, Singh R (2020) Neutrophils in the tumor microenvironment. Adv Exp Med Biol 1224:1\u201320. https:\/\/doi.org\/10.1007\/978-3-030-35723-8","journal-title":"Adv Exp Med Biol"},{"issue":"18","key":"5465_CR59","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.7150\/jca.25691","volume":"9","author":"R Yang","year":"2018","unstructured":"Yang R, Chang Q, Meng X, Gao N, Wang W (2018) Prognostic value of systemic immune inflammation index in cancer: a meta-analysis. J Cancer 9(18):3295\u20133302. https:\/\/doi.org\/10.7150\/jca.25691","journal-title":"J Cancer"},{"issue":"2","key":"5465_CR60","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/jcsm.12275","volume":"9","author":"T Zhou","year":"2018","unstructured":"Zhou T, Wang B, Liu H, Yang K, Thapa S, Zhang H, Li L, Yu S (2018) Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients. J Cachexia Sarcopenia Muscle 9(2):306\u2013314. https:\/\/doi.org\/10.1002\/jcsm.12275","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05465-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05465-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05465-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:09:07Z","timestamp":1700345347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05465-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":60,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5465"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05465-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Stellenbosch by the Health Research Ethics Committee (HREC), reference number S19\/10\/223.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}